As the number of people diagnosed with diabetes continues to grow, an increasing number of products marketed under the guise of "dietary supplements" or "over-the-counter drugs" promising to prevent, ...

More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.

The FDA determined that Novo Nordisk’s obesity and diabetes drugs are no longer in short supply. Elsewhere, Concentra made a ...

Antibiotic misuse, poor infection control, and high transmission rates of resistant pathogens fuel antimicrobial resistance and superbugs in hospitals.